# Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy

> **NCT00420966** · — · COMPLETED · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 25003 (actual)

## Conditions studied

- Lower Respiratory Tract Infection
- Respiratory Syncytial Virus Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00420966
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2017-06-26
- **Final completion:** 2017-06-26
- **Target enrollment:** 25003 (ACTUAL)
- **Last updated:** 2018-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00420966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00420966, "Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00420966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*